Home > Products > Food & Nutrition > Nutritional Ingredients > 1-((5-IODONAPHTHALEN-1-YL)SULFONYL)-1,4-DIAZEPANE HYDROCHLORIDE
1-((5-IODONAPHTHALEN-1-YL)SULFONYL)-1,4-DIAZEPANE HYDROCHLORIDE structure, CAS 110448-33-4

1-((5-IODONAPHTHALEN-1-YL)SULFONYL)-1,4-DIAZEPANE HYDROCHLORIDE

CAS Number110448-33-4

Synonyms1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride; ML-7 HYDROCHLORIDE; 1H-1,4-Diazepine, hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-, hydrochloride (1:1); MFCD00065524; 1-[(5-Iodo-1-naphthyl)sulfonyl]-1,4-diazepane hydrochloride (1:1); ML-7 (hydrochloride)

Molecular FormulaC15H18ClIN2O2S

Molecular Weight452.74

Purity≥98 (TLC)%

Density

Boiling Point542.7ºC at 760 mmHg

Melting Point246-249ºC dec.

Flash Point

Appearancepowder

EINECS0

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1103791 Purity: ≥98 (TLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 110448-33-4 ] Purity: ≥98 (TLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number110448-33-4
Catalog No.2A-1103791
Chinese NameML-7盐酸盐
Synonyms1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride; ML-7 HYDROCHLORIDE; 1H-1,4-Diazepine, hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-, hydrochloride (1:1); MFCD00065524; 1-[(5-Iodo-1-naphthyl)sulfonyl]-1,4-diazepane hydrochloride (1:1); ML-7 (hydrochloride)
Molecular FormulaC15H18ClIN2O2S
Molecular Weight452.74
Purity≥98 (TLC)
Boiling Point542.7ºC at 760 mmHg
Melting Point246-249ºC dec.
Appearancepowder
Storage ConditionStore airtight in a cool, dry warehouse. Refrigera
ApplicationML-7 hydrochloride is a naphthalenesulfonamide derivative that potently inhibits MLCK (IC50=300 nM) and TRPC6 channels (IC50>10 μM).
EINECS0
HTC0
UN(IATA)0
PubChem ID24278490
MDL NumberMFCD00065524
SMILESCl.Ic1cccc2c(cccc12)S(=O)(=O)N3CCCNCC3
InChI1S/C15H17IN2O2S.ClH/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18;/h1-2,4-7,17H,3,8-11H2;1H
InChI KeyKDDALCDYHZIZMH-UHFFFAOYSA-N
NACRES CodeNA.77
UNSPSC12352200
MSDSmsds/103791_1_110448_33_4.pdf
BioactivityML-7 hydrochloride is a naphthalene sulphonamide derivative, potently inhibits MLCK (IC50=300 nM) and TRPC6 channel (IC50>10 μM). Related Catalog Signaling Pathways >> Cytoskeleton >> Myosin Research Areas >> Cancer Target IC50: 300 nM (MLCK)[1] In Vitro ML-7 hydrochloride inhibits rabbit portal vein α1-adrenoceptor NSCC with IC50 of 0.8 μM[1]. The myosin light chain kinase (MLCK) inhibitor ML-7 hydrochloride (3 μ M and 10 μM) also attenuates the Dexmedetomidine (DMT)-induced contraction (p<0.05 versus control)[2]. In Vivo In sham operated animals Evans Blue extravasation is not different between ML-7 hydrochloride and vehicle group (sham+vehicle: 0.26±0.02 OD/g; sham+ML-7: 0.26±0.02 OD/g). After CCI inhibition of MLCK with ML-7 results in a significant lower amount of intracerebral Evans Blue compared to vehicle treated animals (CCI+vehicle: 0.42±0.04 OD/g; CCI+ML-7: 0.35±0.05 OD/g, p=0.048)[3]. Animal Admin Mice[3] Mice are treated with intraperitoneal injection of the selective MLCK inhibitor ML-7 (1 mg/kg) or vehicle solution (0.9% NaCl,control group) 1 h prior to and 6 h after trauma. Hemispheric brain water content and neurological function are measured 24 h after controlled cortical impact (CCI) in animals randomized to: (i) vehicle+sham surgery, (ii) vehicle+CCI, (iii) ML-7+shamsurgery or (iv) ML-7+CCI (n=8 per group) and 15 min after CCI in animals randomized to: (i) vehicle+sham surgery, (ii) vehicle+CCI, (iii) ML-7+sham surgery or (iv) ML-7+CCI (n=6 per group). Mice are treated with intraperitoneal injection of the selective MLCK inhibitor ML-7 (1 mg/kg) or vehicle solution (0.9% NaCl, control group) 1 h prior to and 6 h after trauma. Evans Blue extravasation is determined 24 h after surgery in animals randomized to: (i) vehicle + CCI or (ii) ML-7+CCI (n=5 per group) and in animals randomized to (iii) vehicle + sham surgery or (iv) ML-7+sham surgery (n=6 per group). ICP is measured 24 h CCI and sham surgery. References [1]. Shi J, et al. Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293cells. Br J Pharmacol. 2007 Sep;152(1):122-31. [2]. Yu J, et al. Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation. Int J Med Sci. 2015 Sep 4;12(9):727-36. [3]. Luh C, et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J Neurochem. 2010 Feb;112(4):1015-25. Chemical & Physical Properties Boiling Point 542.7ºC at 760 mmHg Melting Point 246-249ºC dec. Molecular Formula C15H18ClIN2O2S Molecular Weight 452.738 Flash Point 282ºC Exact Mass 451.982208 PSA 57.79000 LogP 4.57790 InChIKey KDDALCDYHZIZMH-UHFFFAOYSA-N SMILES Cl.O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1 Storage condition -20℃
Use ofProperties Name 1-((5-Iodonaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride Synonym More Synonyms ML-7 hydrochloride Biological Activity Related Catalog Signaling Pathways >> Cytoskeleton >> Myosin Research Areas >> Cancer IC50: 300 nM (MLCK)[1] In Vitro ML-7 hydrochloride inhibits rabbit portal vein α1-adrenoceptor NSCC with IC50 of 0.8 μM[1]. The myosin light chain kinase (MLCK) inhibitor ML-7 hydrochloride (3 μ M and 10 μM) also attenuates the Dexmedetomidine (DMT)-induced contraction (p<0.05 versus control)[2]. References [2]. Yu J, et al. Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation. Int J Med Sci. 2015 Sep 4;12(9):727-36. [3]. Luh C, et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J Neurochem. 2010 Feb;112(4):1015-25. Chemical & Physical Properties Exact Mass 451.982208 PSA 57.79000 LogP 4.57790 InChIKey KDDALCDYHZIZMH-UHFFFAOYSA-N Storage condition -20℃
Transport InfoProduct name: 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine, hydrochloride
Related Products in Nutritional Ingredients
1,4-OXAZEPANE5638-60-82A-0103521
1,4-OXAZEPANE HYDROCHLORIDE178312-62-42A-0103522
1,4-OXAZEPANE-2-CARBOXYLIC ACID HYDROCHLORIDE1186663-62-62A-0103523
1,4-THIAZEPANE101184-85-42A-0103526
1,4-THIAZEPANE 1-OXIDE HYDROCHLORIDE108724-14-72A-0103527
1-((TETRAHYDRO-2H-PYRAN-2-YL)METHYL)AZEPANE-2,5-DIONE915924-81-12A-0103818
1-(1-METHYLPIPERIDIN-4-YL)-1,4-DIAZEPANE202992-02-72A-0103918
1-(2-(PIPERIDIN-4-YL)ETHYL)AZEPANE96901-05-22A-0104246
1-(2-(PYRIDIN-4-YL)ETHYL)-1,4-DIAZEPANE887833-52-52A-0104255
1-(3-CHLOROPYRIDIN-2-YL)-1,4-DIAZEPANE902837-06-32A-0105064
Browse all Nutritional Ingredients products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA